Daikaffil Chemicals India Ltd
Incorporated in 1992, Daikaffil Chemicals India Ltd manufactures and trades Organic Dyes and
Intermediaries[1]
- Market Cap ₹ 28.0 Cr.
- Current Price ₹ 46.6
- High / Low ₹ 170 / 28.5
- Stock P/E
- Book Value ₹ 11.3
- Dividend Yield 0.00 %
- ROCE %
- ROE -32.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 4.13 times its book value
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| 34.43 | 27.41 | 26.44 | 22.82 | 13.35 | |
| 31.45 | 24.25 | 21.77 | 19.56 | 15.28 | |
| Operating Profit | 2.98 | 3.16 | 4.67 | 3.26 | -1.93 |
| OPM % | 8.66% | 11.53% | 17.66% | 14.29% | -14.46% |
| -0.16 | 0.56 | 0.56 | 0.86 | 0.05 | |
| Interest | 0.26 | 0.14 | 0.07 | 0.05 | 0.01 |
| Depreciation | 0.42 | 0.40 | 1.48 | 0.97 | 0.36 |
| Profit before tax | 2.14 | 3.18 | 3.68 | 3.10 | -2.25 |
| Tax % | 28.04% | 33.65% | 33.42% | 23.55% | -1.78% |
| 1.54 | 2.11 | 2.45 | 2.37 | -2.21 | |
| EPS in Rs | 2.58 | 3.50 | 4.07 | 3.98 | -3.68 |
| Dividend Payout % | 30.97% | 28.57% | 41.80% | 30.13% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | 22% |
| 1 Year: | -72% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -33% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Reserves | 5.22 | 6.60 | 18.38 | 19.54 | 0.78 |
| 1.89 | 0.71 | 0.00 | 0.00 | 0.00 | |
| 7.03 | 5.74 | 3.51 | 4.88 | 2.64 | |
| Total Liabilities | 20.14 | 19.05 | 27.89 | 30.42 | 9.42 |
| 5.37 | 5.34 | 15.14 | 14.69 | 2.07 | |
| CWIP | 0.00 | 0.04 | 0.09 | 0.01 | 0.25 |
| Investments | 0.04 | 0.19 | 0.22 | 2.22 | 0.25 |
| 14.73 | 13.48 | 12.44 | 13.50 | 6.85 | |
| Total Assets | 20.14 | 19.05 | 27.89 | 30.42 | 9.42 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| 1.71 | 0.70 | 5.04 | 2.64 | ||
| -0.51 | -0.46 | -0.92 | -2.69 | ||
| -0.59 | -0.58 | -0.72 | -1.23 | ||
| Net Cash Flow | 0.60 | -0.33 | 3.39 | -1.28 | |
| Free Cash Flow | 1.24 | 0.30 | 4.11 | 2.21 | |
| CFO/OP | 89% | 52% | 138% | 108% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 72.51 | 93.88 | 40.03 | 74.22 | 54.41 |
| Inventory Days | 70.55 | 81.88 | 82.17 | 84.50 | 99.99 |
| Days Payable | 85.49 | 69.66 | 34.20 | 80.96 | 60.14 |
| Cash Conversion Cycle | 57.58 | 106.10 | 88.00 | 77.76 | 94.25 |
| Working Capital Days | 47.92 | 84.03 | 77.03 | 94.85 | 87.49 |
| ROCE % | 24.73% | 19.71% | 12.53% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Sales Percentage % ・Standalone data |
|
|||||||||||
| Revenue from Operations (Gross Sales Value) INR Lakhs ・Standalone data |
||||||||||||
| Headcount (Permanent Employees) Number ・Standalone data |
||||||||||||
| Customer Concentration (Sales to Single Largest Customer) % ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 49m
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
2h - Mikusu India bought 5,040 Daikaffil shares on June 15, 2026; holding rose to 49.40%.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
1d - Mikusu India bought 3,700 Daikaffil shares on June 12, lifting stake to 49.32%.
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
13 Jun - Mikusu India bought 3,700 shares of Daikaffil Chemicals on June 12, 2026, raising stake to 49.32%.
-
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
12 Jun - Mikusu India bought 8,144 shares on June 11, 2026; stake rose to 49.26%.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
DCIL is in the business of manufacturing
and trading of organic chemicals and intermediaries and trading of chemicals